Correlation Between DexCom and Entera Bio
Can any of the company-specific risk be diversified away by investing in both DexCom and Entera Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DexCom and Entera Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DexCom Inc and Entera Bio, you can compare the effects of market volatilities on DexCom and Entera Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DexCom with a short position of Entera Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of DexCom and Entera Bio.
Diversification Opportunities for DexCom and Entera Bio
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between DexCom and Entera is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding DexCom Inc and Entera Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entera Bio and DexCom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DexCom Inc are associated (or correlated) with Entera Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entera Bio has no effect on the direction of DexCom i.e., DexCom and Entera Bio go up and down completely randomly.
Pair Corralation between DexCom and Entera Bio
Given the investment horizon of 90 days DexCom Inc is expected to generate 0.58 times more return on investment than Entera Bio. However, DexCom Inc is 1.73 times less risky than Entera Bio. It trades about 0.07 of its potential returns per unit of risk. Entera Bio is currently generating about -0.08 per unit of risk. If you would invest 7,236 in DexCom Inc on September 3, 2024 and sell it today you would earn a total of 563.00 from holding DexCom Inc or generate 7.78% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
DexCom Inc vs. Entera Bio
Performance |
Timeline |
DexCom Inc |
Entera Bio |
DexCom and Entera Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with DexCom and Entera Bio
The main advantage of trading using opposite DexCom and Entera Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DexCom position performs unexpectedly, Entera Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entera Bio will offset losses from the drop in Entera Bio's long position.DexCom vs. Tandem Diabetes Care | DexCom vs. Inspire Medical Systems | DexCom vs. Penumbra | DexCom vs. Insulet |
Entera Bio vs. Seres Therapeutics | Entera Bio vs. DiaMedica Therapeutics | Entera Bio vs. Lyra Therapeutics | Entera Bio vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |